CUE BIOLOGICS Trademark

Trademark Overview


On Tuesday, September 5, 2017, a trademark application was filed for CUE BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the CUE BIOLOGICS trademark a serial number of 87595887. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, August 15, 2018. This trademark is owned by Cue BioPharma, Inc.. The CUE BIOLOGICS trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for treating cancer, infectious diseases and autoimmune diseases; immunotherapeutic preparations for treating cancer, infectious diseases, and autoimmune diseases; biopharmaceutical preparations for modulating T- cells, treating infection diseases, treating cancer, and treating autoimmune disorders; Biopharmaceutical preparations containing an active agent for modulating T-cells in order to treat infectious diseases, cancer, and autoimmune disorders; Pharmaceutical preparations containing an active agent for modulating T-cells, treating infectious diseases, treating cancer, and treating autoimmune disorders; none of the foregoing for medical diagnostic or analyte detection purposes
cue biologics

General Information


Serial Number87595887
Word MarkCUE BIOLOGICS
Filing DateTuesday, September 5, 2017
Status601 - ABANDONED - EXPRESS
Status DateWednesday, August 15, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"BIOLOGICS"
Goods and ServicesBiopharmaceutical preparations for treating cancer, infectious diseases and autoimmune diseases; immunotherapeutic preparations for treating cancer, infectious diseases, and autoimmune diseases; biopharmaceutical preparations for modulating T- cells, treating infection diseases, treating cancer, and treating autoimmune disorders; Biopharmaceutical preparations containing an active agent for modulating T-cells in order to treat infectious diseases, cancer, and autoimmune disorders; Pharmaceutical preparations containing an active agent for modulating T-cells, treating infectious diseases, treating cancer, and treating autoimmune disorders; none of the foregoing for medical diagnostic or analyte detection purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCue BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Thursday, August 16, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 16, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 15, 2018ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, August 15, 2018ABANDONMENT - EXPRESS MAILED
Tuesday, August 14, 2018TEAS EXPRESS ABANDONMENT RECEIVED
Friday, August 3, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 4, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 4, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, April 4, 2018SUSPENSION LETTER WRITTEN
Friday, March 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 29, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 13, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 13, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, February 13, 2018SUSPENSION LETTER WRITTEN
Tuesday, January 16, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, January 16, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 16, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, January 16, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, December 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 21, 2017NON-FINAL ACTION E-MAILED
Thursday, December 21, 2017NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, December 12, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, December 11, 2017ASSIGNED TO EXAMINER
Monday, September 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 8, 2017NEW APPLICATION ENTERED IN TRAM